WallStSmart
STIM

Neuronetics Inc

NASDAQ: STIM · HEALTHCARE · MEDICAL DEVICES

$1.94
+14.12% today

Updated 2026-04-30

Market cap
$117.59M
P/E ratio
P/S ratio
0.79x
EPS (TTM)
$-0.59
Dividend yield
52W range
$1 – $5
Volume
1.9M

Neuronetics Inc (STIM) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item2016201720182019202020212022202320242025
Revenue$34.23M$40.43M$52.78M$62.66M$49.24M$55.31M$65.21M$71.35M$74.89M$149.16M
Revenue growth (YoY)+18.1%+30.5%+18.7%-21.4%+12.3%+17.9%+9.4%+5.0%+99.2%
Cost of revenue$6.62M$9.63M$12.45M$15.39M$11.55M$11.65M$15.48M$19.64M$20.73M$76.85M
Gross profit$27.61M$30.80M$40.33M$47.27M$37.69M$43.66M$49.72M$51.70M$54.16M$72.31M
Gross margin80.7%76.2%76.4%75.4%76.5%78.9%76.3%72.5%72.3%48.5%
R&D$8.22M$7.94M$8.23M$13.75M$9.20M$7.92M$9.34M$9.52M$12.77M$6.58M
SG&A$6.93M$8.57M$13.67M$17.46M$18.24M$25.55M$25.52M$25.43M$30.32M$49.70M
Operating income$-9.34M$-13.61M$-19.83M$-26.93M$-22.31M$-27.56M$-35.11M$-30.55M$-34.56M$-31.44M
Operating margin-27.3%-33.7%-37.6%-43.0%-45.3%-49.8%-53.8%-42.8%-46.2%-21.1%
EBITDA$-8.73M$-12.58M$-19.53M$-27.19M$-25.89M$-26.81M$-31.96M$-22.76M$-34.37M$-27.97M
EBITDA margin-25.5%-31.1%-37.0%-43.4%-52.6%-48.5%-49.0%-31.9%-45.9%-18.8%
EBIT$-9.40M$-13.25M$-20.41M$-28.26M$-26.83M$-27.87M$-33.61M$-24.77M$-36.44M$-31.44M
Interest expense$1.83M$2.81M$3.69M$3.69M$4.52M$3.30M$3.60M$5.42M$7.29M$8.41M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-11.23M$-16.06M$-24.10M$-29.04M$-27.45M$-31.19M$-37.16M$-30.19M$-43.71M$-39.00M
Net income growth (YoY)-42.9%-50.1%-20.5%+5.5%-13.6%-19.1%+18.8%-44.8%+10.8%
Profit margin-32.8%-39.7%-45.7%-46.4%-55.7%-56.4%-57.0%-42.3%-58.4%-26.1%